TransMedics Group, Inc.
TMDX
$89.36
$0.951.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 668.47M | 635.89M | 605.49M | 566.35M | 531.29M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 668.47M | 635.89M | 605.49M | 566.35M | 531.29M |
| Cost of Revenue | 276.12M | 260.15M | 242.69M | 224.95M | 213.62M |
| Gross Profit | 392.35M | 375.74M | 362.81M | 341.41M | 317.68M |
| SG&A Expenses | 218.27M | 204.53M | 185.17M | 180.63M | 177.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 586.86M | 541.45M | 496.91M | 470.40M | 454.72M |
| Operating Income | 81.61M | 94.44M | 108.58M | 95.95M | 76.58M |
| Income Before Tax | 72.55M | 89.33M | 107.52M | 92.88M | 74.09M |
| Income Tax Expenses | -79.15M | -82.59M | -82.77M | 1.11M | 2.43M |
| Earnings from Continuing Operations | 151.70 | 171.92 | 190.29 | 91.77 | 71.66 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 151.70M | 171.92M | 190.29M | 91.77M | 71.66M |
| EBIT | 81.61M | 94.44M | 108.58M | 95.95M | 76.58M |
| EBITDA | 115.23M | 124.95M | 134.07M | 120.15M | 99.90M |
| EPS Basic | 4.43 | 5.03 | 5.58 | 2.71 | 2.12 |
| Normalized Basic EPS | 1.32 | 1.64 | 1.98 | 1.71 | 1.37 |
| EPS Diluted | 3.84 | 4.35 | 4.86 | 2.48 | 1.94 |
| Normalized Diluted EPS | 1.13 | 1.39 | 1.66 | 1.45 | 1.17 |
| Average Basic Shares Outstanding | 137.30M | 136.63M | 135.97M | 135.34M | 134.67M |
| Average Diluted Shares Outstanding | 158.58M | 158.43M | 162.15M | 156.43M | 151.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |